Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death

Oncogene
L LiuT O Tollefsbol

Abstract

The polycomb group protein BMI1 has been shown to support normal stem cell proliferation via its putative stem cell factor function, but it is not known if BMI1 may also act as a cancer stem cell factor to promote cancer development. To determine the role of human BMI1 in cancer growth and survival, we performed a loss-of-function analysis of BMI1 by RNA interference (RNAi) in both normal and malignant human cells. Our results indicate that BMI1 is crucial for the short-term survival of cancer cells but not of normal cells. We also demonstrated that loss of BMI1 was more effective in suppressing cancer cell growth than retinoid-treatment, and surviving cancer cells showed significantly reduced tumorigenicity. The cancer-specific growth retardation was mediated by an increased level of apoptosis and a delayed cell cycle progression due to the loss of BMI1. By comparison, BMI1 deficiency caused only a moderate inhibition of the cell cycle progression in normal lung cells. In both normal and cancer cells, the loss of BMI1 led to an upregulation of INK4A-ARF, but with no significant effect on the level of telomerase gene expression, suggesting that other BMI1-cooperative factors in addition to INK4A-ARF activation may be involved i...Continue Reading

Associated Clinical Trials

References

Dec 17, 2002·Molecular and Cellular Biology·Koji ItahanaGoberdhan P Dimri
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Jan 23, 2004·Nature Reviews. Cancer·Ricardo PardalSean J Morrison
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Jun 21, 2005·Genes & Development·Sophia W M BruggemanMaarten van Lohuizen
Jun 25, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Olga ShakhovaSilvia Marino
Aug 3, 2005·Nature Reviews. Molecular Cell Biology·Sovana Adhikary, Martin Eilers

❮ Previous
Next ❯

Citations

Jan 29, 2008·International Journal of Hematology·Yoshihiro Takihara
Jul 23, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·M V S ParvathiB V Suresh
Mar 14, 2007·Expert Reviews in Molecular Medicine·Stuart P Atkinson, W Nicol Keith
Jun 17, 2010·The Journal of Biological Chemistry·Sha MengZhigang Lu
Oct 25, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tatyana A KlimovaNavdeep S Chandel
Mar 24, 2010·Current Opinion in Hematology·Jan J Schuringa, Edo Vellenga
Apr 25, 2007·Molecular and Cellular Biology·Dmitri WiederschainJohn D Benson
Aug 15, 2008·Cancer Research·Dorothea DouglasElizabeth R Lawlor
Nov 30, 2011·Epigenomics·Koji Itahana, Goberdhan P Dimri
Feb 22, 2013·Molecular Cancer Therapeutics·Zebin WangPradip Raychaudhuri
Nov 10, 2009·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Randall S Gieni, Michael J Hendzel
Jan 2, 2013·Pathology·Rajmohan MuraliRichard A Scolyer
Apr 13, 2011·Oral Oncology·Hui ChenJie Tian
May 3, 2008·Biochemical and Biophysical Research Communications·Li QinLi-Bing Song
Mar 25, 2008·Molecular and Cellular Endocrinology·Shiqing ZhangXueming Zhang
Mar 19, 2008·Neuropathology and Applied Neurobiology·V HäyryN N Nupponen
Nov 29, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Cathrine K FogAnders H Lund
Nov 11, 2011·International Journal of Cancer. Journal International Du Cancer·Pietro FerruzziAnnette Bakker
Aug 23, 2011·International Journal of Cancer. Journal International Du Cancer·Xin ZhangZhaogang Dong
Apr 2, 2014·Translational Research : the Journal of Laboratory and Clinical Medicine·Scott M LangevinKarl T Kelsey
May 15, 2015·Cellular and Molecular Life Sciences : CMLS·Hong QiuGaoliang Ouyang
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Fubin ZhangTao Xin
Jun 17, 2014·Oncogene·P-Y Tung, P S Knoepfler
Oct 16, 2007·Cancer Cell·Sophia W M BruggemanMaarten van Lohuizen
Aug 19, 2010·Blood·Daniel Martin-PerezMargarita Sanchez-Beato
Nov 9, 2016·Nature Communications·Felicia GrayTomasz Cierpicki

❮ Previous
Next ❯

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis